Ironwood Pharma (IRWD) Misses Q2 EPS by 6c

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $14.6 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Citi cuts Weibo stock rating to Neutral, lowers price target
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance